1. Home
  2. SUPN vs KWR Comparison

SUPN vs KWR Comparison

Compare SUPN & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$55.61

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$141.70

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
KWR
Founded
2005
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
SUPN
KWR
Price
$55.61
$141.70
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$61.60
$152.50
AVG Volume (30 Days)
740.4K
161.6K
Earning Date
05-21-2026
05-26-2026
Dividend Yield
N/A
1.43%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
$1,888,634,000.00
Revenue This Year
$23.19
$5.05
Revenue Next Year
$17.65
$4.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.66
52 Week Low
$29.16
$95.91
52 Week High
$59.68
$183.01

Technical Indicators

Market Signals
Indicator
SUPN
KWR
Relative Strength Index (RSI) 63.79 29.25
Support Level $47.95 $129.91
Resistance Level $58.67 $143.28
Average True Range (ATR) 2.26 7.54
MACD 0.38 -4.31
Stochastic Oscillator 60.13 7.19

Price Performance

Historical Comparison
SUPN
KWR

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

Share on Social Networks: